Cannabis News Box

Cannabis Science will expand scope of sponsored research to include neurological conditions

Cannabis Science will expand scope of sponsored research to include neurological conditions

Bethan Rose Jenkins, Cannabis News Writer/Editorial

March 11, 2019


Filed under Research

Cannabis Science, Inc. (OTC: CBIS), a U.S.-based company that develops cannabinoid-based medicines,  has revealed its plans to broaden the extent of its sponsored medical cannabis research in Nigeria. Neurological conditions, such as Post-Traumatic Stress Disorder (PTSD), will be added to its re...

Cannabis Science buys patent for CBN compositions to treat sleep, anxiety and neurobehavioral disorders

Cannabis Science buys patent for CBN compositions to treat sleep, anxiety and neurobehavioral disorders

Bethan Rose Jenkins, Cannabis News Writer/Editorial

December 5, 2018


Filed under News, Research, Showcase

Cannabis Science, Inc. (OTC: CBIS), a U.S. developer of cannabinoid-based medicines, has proudly confirmed receipt of Issued US Patent Number 9,763,991 For Compositions of Cannabinol (CBN) for Treatment of Various Neurobehavioral Disorders, Sleep Deprivation (Insomnia), Anxiety Disorders (ADHD), and P...

cannabis science